Abstract: This disclosure describes a method of treating hyperlipidemia and atherosclerotic lesions with 4-(monoalkylamino)benzoic acid amides and compositions therefor.
Abstract: This disclosure describes a novel process for the preparation of 1-(lower alkyl)substituted derivatives of 6-n-propyl-8-alkylimidazo[1,5-d]-as-triazin-4(3H)-ones which are useful as anti-asthmatic agents.
Type:
Grant
Filed:
February 11, 1983
Date of Patent:
July 10, 1984
Assignee:
American Cyanamid Company
Inventors:
Sivaraman Raghu, James Salvatore, Steven L. Peake
Abstract: This disclosure describes symmetrical 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones useful as chelating agents and for inhibiting the growth of transplanted mouse tumors.
Abstract: This disclosure describes new compounds and compositions of matter useful as anti-asthmatic agents and the method of meliorating asthma in mammals therewith, the novel active ingredients of said compositions of matter being certain 1-substituted-6-n-propyl-8-methylimidazo [1,5-d]-as-triazin-4(3H)-ones and/or the pharmacologically acceptable acid-addition salts thereof.
Abstract: The present invention concerns certain novel substituted 3-azabicyclo[3.1.0]hexanes and a method of treating depression and stress in a warm-blooded animal, comprising the administration of substituted 3-azabicyclo[3.1.0]hexanes.
Type:
Grant
Filed:
May 10, 1982
Date of Patent:
March 6, 1984
Assignee:
American Cyanamid Company
Inventors:
Joseph W. Epstein, Arnold C. Osterberg, Herbert J. Brabander
Abstract: This disclosure describes symmetrical 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones useful as chelating agents and for inhibiting the growth of transplanted mouse tumors.
Abstract: This disclosure describes 1-(aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones useful as chelating agents and for inhibiting the growth of transplanted mouse tumors.
Abstract: This disclosure describes novel 15-deoxy-16-hydroxy-16-substituted prostanoic acids and congeners thereof having utility as bronchodilators as hypotensive agents, and as agents for the control of excessive gastric secretion.
Type:
Grant
Filed:
September 25, 1981
Date of Patent:
January 31, 1984
Assignee:
American Cyanamid Company
Inventors:
Middleton B. Floyd, Jr., Martin J. Weiss, Charles V. Grudzinskas, Sow-Mei Lai Chen
Abstract: This disclosure describes novel 1-(5-amino-4H-1,2,4-triazol-3-yl)-4-substituted-piperazines which are useful as hypotensive agents in mammals.
Type:
Grant
Filed:
March 22, 1982
Date of Patent:
December 20, 1983
Assignee:
American Cyanamid Company
Inventors:
Andrew S. Tomcufcik, Walter E. Meyer, John P. Dusza
Abstract: This disclosure describes certain substituted 9,10-bis(2-aminoethoxy)anthracenes which are useful as modulators of the immune response system in warm-blooded animals and for inducing the regression of tumors in such animals.
Abstract: This disclosure describes compositions of matter useful as inhibitors of transplanted mouse tumor growth, the active ingredient of said compositions of matter being 1,4-bis(3-aminopropylamino)-5,8-dihydroxyanthraquinone or the non-toxic acid-addition salts thereof.
Abstract: This disclosure describes a novel process for the preparation of 1-(lower alkyl)substituted derivatives of 6-n-propyl-8-alkylimidazo[1,5-d]-as-triazin-4(3H)-ones which are useful as anti-asthmatic agents.
Type:
Grant
Filed:
February 10, 1982
Date of Patent:
July 26, 1983
Assignee:
American Cyanamid Co.
Inventors:
Sivaraman Raghu, James S. Farina, Steven L. Peake
Abstract: This disclosure describes certain novel 3-(.alpha.-substituted-benzyl)-2,3-dihydrothiazolo[3,2-a][1,3]diazacyclan- 3-ols which are useful as diuretic agents.
Type:
Grant
Filed:
January 29, 1982
Date of Patent:
July 12, 1983
Assignee:
American Cyanamid Company
Inventors:
Andrew S. Tomcufcik, William B. Wright, Jr., Joseph W. Marsico, Jr.